Soluble interleukin-2 receptors in pulmonary tuberculosis

Area of Science:

• Immunology
• Pulmonology
• Biochemistry

Background:

• Soluble interleukin-2 receptor (IL-2R) is a marker of immune system activation.
• Pulmonary diseases, including tuberculosis, involve complex immune responses.

Purpose of the Study:

• To investigate serum IL-2R levels in patients with pulmonary tuberculosis compared to other pulmonary conditions and healthy individuals.
• To assess the utility of IL-2R as a biomarker for tuberculosis diagnosis and treatment monitoring.

Main Methods:

• Serum samples were collected from patients with pulmonary tuberculosis, nontuberculous pulmonary diseases (bacterial pneumonia, lower respiratory tract infection, lung cancer), and healthy controls.
• Serum IL-2R levels were quantified using immunoassays.
• Correlation analysis was performed between IL-2R levels and adenosine deaminase (ADA) levels in tuberculosis patients.

Main Results:

• Patients with pulmonary tuberculosis exhibited significantly higher serum IL-2R levels than healthy controls.
• Elevated IL-2R levels were also observed in patients with nontuberculous pulmonary diseases, indicating a lack of specificity for tuberculosis.
• Successful tuberculosis treatment led to a decrease in IL-2R levels to normal ranges.
• Serum IL-2R levels in tuberculosis patients showed a strong positive correlation with ADA levels.
• Elevated IL-2R in tuberculosis is attributed to mononuclear cell activation, not cell death.

Conclusions:

• Serum IL-2R is elevated in pulmonary tuberculosis and other lung diseases.
• Decreasing IL-2R levels during treatment suggest its potential as a biomarker for monitoring tuberculosis treatment response.
• IL-2R measurement may aid in the diagnosis and management of tuberculosis, often in conjunction with other markers like ADA.